NYMC Faculty Publications
Primary Aldosteronism: Cardiovascular Risk, Diagnosis, and Management
Author Type(s)
Faculty
DOI
10.1097/CRD.0000000000000281
Journal Title
Cardiology in Review
First Page
84
Last Page
91
Document Type
Review Article
Publication Date
3-2020
Department
Medicine
Abstract
Primary aldosteronism remains a leading cause of secondary hypertension, and its diagnosis and management continue to pose a challenge for clinicians. In this article, we review the diagnosis of primary aldosteronism along with its cardiovascular manifestations. Treatment is described depending on the diagnostic outcome, focusing on medical management with mineralocorticoid receptor antagonists and unilateral adrenalectomy. Although screening and diagnosing hyperaldosteronism follows well-known algorithms, in practice, physicians may find difficulty establishing the best course of action due to complexity in testing and confirming laterality of aldosterone production by the adrenals. Recognizing and treating primary aldosteronism requires a multidisciplinary approach with primary care physicians, cardiologists, endocrinologists, and radiologists working collaboratively.
Recommended Citation
Pillai, P., Griffith, M., Schwarcz, M. D., & Weiss, I. A. (2020). Primary Aldosteronism: Cardiovascular Risk, Diagnosis, and Management. Cardiology in Review, 28 (2), 84-91. https://doi.org/10.1097/CRD.0000000000000281